Supplemental material
Journal of Dermatological Treatment
Volume 33, 2022 - Issue 5
Short Reports
Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
Selma Atalaya Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlands
https://orcid.org/0000-0002-9671-0386View further author information
https://orcid.org/0000-0002-9671-0386View further author information, Sophie E. Berendsb Department of Hospital Pharmacy, Academic Medical Center, Amsterdam, Netherlandshttps://orcid.org/0000-0002-3236-0698View further author information
https://orcid.org/0000-0002-3236-0698View further author information, Hans M. M. Groenewoudc Department for Health Evidence, Radboud Institute for Health Sciences, Radboudumc, Nijmegen, Netherlandshttps://orcid.org/0000-0002-4974-150XView further author information
https://orcid.org/0000-0002-4974-150XView further author information, Ron A. A. Mathotb Department of Hospital Pharmacy, Academic Medical Center, Amsterdam, Netherlandshttps://orcid.org/0000-0001-8401-0879View further author information
https://orcid.org/0000-0001-8401-0879View further author information, David M. Njood Department of Dermatology, Ziekenhuis Groep Twente, Hengelo, Netherlandshttps://orcid.org/0000-0003-1424-5722View further author information
https://orcid.org/0000-0003-1424-5722View further author information, Johannes M. Mommerse Department of Dermatology, Sint Anna Ziekenhuis, Geldrop, Netherlandshttps://orcid.org/0000-0002-4930-4107View further author information
https://orcid.org/0000-0002-4930-4107View further author information, Paul M. Ossenkoppelef Department of Dermatology, Ziekenhuis Groep Twente, Almelo, Netherlandshttps://orcid.org/0000-0002-7311-7213View further author information
https://orcid.org/0000-0002-7311-7213View further author information, Marjolein I. A. Koetsierg Department of Dermatology, Gelre Ziekenhuizen, Apeldoorn, Netherlandshttps://orcid.org/0000-0002-7823-8380View further author information
https://orcid.org/0000-0002-7823-8380View further author information, Maartje A. Berendsh Department of Dermatology, Slingelandziekenhuis, Doetinchem, Netherlandshttps://orcid.org/0000-0003-3851-1407View further author information
https://orcid.org/0000-0003-3851-1407View further author information, Annick de Vriesi Biologics Lab, Bioanalysis, Sanquin Diagnostic Services, Amsterdam, Netherlandshttps://orcid.org/0000-0001-7570-473XView further author information
https://orcid.org/0000-0001-7570-473XView further author information, Peter C. M. van de Kerkhofa Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlandshttps://orcid.org/0000-0003-0084-3131View further author information
https://orcid.org/0000-0003-0084-3131View further author information, Alfons A. den Broederj Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlandshttps://orcid.org/0000-0002-9012-4079View further author information
https://orcid.org/0000-0002-9012-4079View further author information, Elke M. G. J. de Jonga Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, Netherlands;k Radboud University, Nijmegen, Netherlandshttps://orcid.org/0000-0003-3872-5704View further author information
https://orcid.org/0000-0003-3872-5704View further author information & Juul M. P. A. van den Reeka Department of Dermatology, Radboudumc, Nijmegen René Descartesdreef 1, Nijmegen, NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0002-3642-2673View further author information
https://orcid.org/0000-0002-3642-2673View further author information show all